The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review



Wilding, John PH ORCID: 0000-0003-2839-8404, Evans, Marc, Fernando, Kevin, Luis Gorriz, Jose, Cebrian, Ana, Diggle, Jane, Hicks, Debbie, James, June, Newland-Jones, Philip, Ali, Amar
et al (show 6 more authors) (2022) The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review. DIABETES THERAPY, 13 (5). 847 - 872.

Access the full-text of this item by clicking on the Open Access link.
[img] Text
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mell.pdf - Published version

Download (1MB) | Preview
Item Type: Article
Uncontrolled Keywords: SGLT2 inhibitors, Oral glucose-lowering medicines, Type 2 diabetes mellitus, Prescribing tools, Heart failure, Chronic kidney disease, Diabetic kidney disease, Cardiovascular disease, Cardiovascular risk, Cardiorenal protection
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 13 May 2022 15:08
Last Modified: 05 Oct 2022 20:02
DOI: 10.1007/s13300-022-01228-w
Open Access URL: https://link.springer.com/article/10.1007/s13300-0...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3154772